Aardvark therapeutics to present at the stifel 2025 virtual cardiometabolic forum

San diego, sept. 23, 2025 (globe newswire) -- aardvark therapeutics, inc. (aardvark) (nasdaq: aard), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, announced that it will present at the stifel 2025 virtual cardiometabolic forum on september 30, 2025 at 9:00 a.m. eastern time.
AARD Ratings Summary
AARD Quant Ranking